GLENMEDE TRUST CO NA - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 152 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$13,000
-59.4%
5,454
+128.7%
0.00%
Q2 2020$32,000
+14.3%
2,385
-47.1%
0.00%
Q1 2020$28,0000.0%4,5060.0%0.00%
Q4 2019$28,000
+27.3%
4,506
-22.9%
0.00%
Q3 2019$22,000
-24.1%
5,847
-5.8%
0.00%
Q2 2019$29,000
-40.8%
6,2100.0%0.00%
Q1 2019$49,000
+104.2%
6,210
+37.8%
0.00%
Q4 2018$24,0004,5060.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders